| South Tyne Healthcare Limited |
| Registered Number:11339938 |
For the year ended 30 November 2024
England and Wales
Unaudited Financial Statements
For the year ended 30 November 2024
South Tyne Healthcare Limited
Contents Page
1
Statement of Financial Position
2 to 6
Notes to the Financial Statements
South Tyne Healthcare Limited
Statement of Financial Position
2023
2024
848,805
910,165
2
| Property, plant and equipment |
14,301
6,330
3
863,106
916,495
31,288
34,804
4
| Trade and other receivables |
275,665
181,565
5
131,239
| Cash and cash equivalents |
80,124
296,493
438,192
| Trade and other payables: amounts falling due within one |
| year |
(445,151)
(361,907)
6
(6,959)
(65,414)
Net current liabilities
| Total assets less current liabilities |
797,692
909,536
| Trade and other payables: amounts falling due after more |
| than one year |
(834,899)
(754,247)
7
43,445
Net assets
74,637
2
2
43,443
74,635
43,445
74,637
Shareholders' funds
| For the year ended 30 November 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
| The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2024 in accordance with Section 476 of the Companies Act 2006 |
| The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the |
| end of each financial year and of its profit or loss for each financial year in accordance with the requirements |
| of Section 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 |
| relating to financial statements, so far as applicable to the company. |
| In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
| The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
1 of 6
For the year ended 30 November 2024
South Tyne Healthcare Limited
Statement of Financial Position Continued
| These financial statements were approved and authorised for issue by the Board on 10 July 2025 and were signed by: |
| The notes form part of these financial statements |
2 of 6
For the year ended 30 November 2024
South Tyne Healthcare Limited
Notes to the Financial Statements
Statutory Information
| South Tyne Healthcare Limited is a private limited company, limited by shares, domiciled in England and Wales, |
| registration number 11339938. |
| Principal place of business: |
47 Gaskell Avenue
South Shields
NE34 9TQ
10 Grange Terrace
Sunderland
SR2 7DF
| The presentation currency is £ sterling. |
Basis of preparing the financial statements
| These financial statements have been prepared in accordance with the provisions of Section 1A of Financial |
| Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and |
| the Companies Act 2006. The financial statements have been prepared under the historical costs convention as |
| modified by the revaluation of certain assets. |
| The financial statements have been prepared on a going concern basis as the directors believe that no material |
| uncertainties exist. The directors have considered the level of funds held and the expected level of income and |
| expenditure for 12 months from authorising these financial statements and have concluded that the company is |
| able to continue as a going concern. |
Intangible assets
| Goodwill represents the excess of the cost of aquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and assumulated impairment losses. Goodwill is consdiered to have a finite useful life and is amortised on a systematic basis over its expected useful life, which is 20 years. For the purpose of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently, when there is an indication that the unit may be impaired. If the receiverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit. With regard to the treatment adopted, the financial statements depart from the specific requirements of the Companies Act to amortise over a definite period for the overriding purpose of giving a true and fair view. |
Property, plant and equipment
| Property, plant and equipment, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: |
Plant and Equipment
3 of 6
For the year ended 30 November 2024
South Tyne Healthcare Limited
Notes to the Financial Statements Continued
Motor Vehicles
Government grants
| Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the company will comply with conditions attaching to them and the grants will be received using the accrual model. |
| 2. Intangible fixed assets |
Goodwill
1,227,193
1,227,193
317,028
61,360
Charge for year
378,388
848,805
910,165
| 3. Property, plant and equipment |
Motor Vehicles
148,221
16,497
131,724
14,831
-
14,831
146,555
16,497
163,052
| Provision for depreciation and impairment |
141,891
11,831
130,060
Charge for year
6,860
2,333
4,527
148,751
14,164
134,587
11,968
2,333
14,301
1,664
4,666
6,330
4 of 6
For the year ended 30 November 2024
South Tyne Healthcare Limited
Notes to the Financial Statements Continued
2023
2024
34,804
31,288
| 5. Trade and other receivables |
2023
2024
104,129
148,845
| Amounts owed by group undertakings and participating interests |
48,012
100,826
29,424
25,994
275,665
181,565
| 6. Trade and other payables: amounts falling due within one year |
2023
2024
| Bank loans and overdraft (secured) |
116,286
119,022
179,596
246,023
| Amounts owed to group undertaking and undertaking in which the |
| company has a participating interest |
15,000
15,000
| Taxation and social security |
34,312
53,479
5,400
-
11,313
11,627
361,907
445,151
| 7. Trade and other payables: amounts falling due after more than one year |
2023
2024
| Bank loans and overdraft (secured) |
726,027
834,899
-
28,220
754,247
834,899
| Analysis of creditors falling due after more than five years: |
267,502
358,809
Loans are secured on the assets to which they relate.
5 of 6
For the year ended 30 November 2024
South Tyne Healthcare Limited
Notes to the Financial Statements Continued
| 8. Average number of persons employed |
During the year the average number of employees were 14 (2023 : 14)
6 of 6